HIV-1 Envgp140 trimers elicit neutralizing antibodies without efficient induction of conformational antibodies
- 29 June 2006
- Vol. 24 (26) , 5442-5451
- https://doi.org/10.1016/j.vaccine.2006.03.063
Abstract
No abstract availableKeywords
This publication has 68 references indexed in Scilit:
- Soluble Mimetics of Human Immunodeficiency Virus Type 1 Viral Spikes Produced by Replacement of the Native Trimerization Domain with aHeterologous Trimerization Motif: Characterization and Ligand Binding AnalysisJournal of Virology, 2005
- Evaluating the Immunogenicity of a Disulfide-Stabilized, Cleaved, Trimeric Form of the Envelope Glycoprotein Complex of Human Immunodeficiency Virus Type 1Journal of Virology, 2005
- Contribution of Virus-Like Particles to the Immunogenicity of Human Immunodeficiency Virus Type 1 Gag-Derived Vaccines in MiceJournal of Virology, 2005
- Selective recognition of oligomeric HIV-1 primary isolate envelope glycoproteins by potently neutralizing ligands requires efficient precursor cleavageVirology, 2004
- Correlates of immune protection in HIV-1 infection: what we know, what we don't know, what we should knowNature Medicine, 2004
- DNA Vaccines: Influenza Virus Challenge of a Th2/Tc2 Immune Response Results in a Th2/Tc1 Response in the LungJournal of Virology, 2004
- DNA Vaccines, Combining Form of Antigen and Method of Delivery to Raise a Spectrum of IFN-γ and IL-4-Producing CD4+ and CD8+ T CellsThe Journal of Immunology, 2003
- Modifications That Stabilize Human Immunodeficiency Virus Envelope Glycoprotein Trimers in SolutionJournal of Virology, 2000
- Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodiesNature Medicine, 2000
- The antigenic structure of the HIV gp120 envelope glycoproteinNature, 1998